Could a simple drug infusion stop a dangerous virus after stem cell transplants?
Disease control
Not yet recruiting
This trial investigates whether giving two low doses of rituximab shortly after a stem cell transplant can prevent serious Epstein-Barr virus (EBV) infections. Participants are adults aged 16-65 who have received a donor stem cell transplant and are at medium-to-high risk for EBV…
Phase: NA • Sponsor: Yang Donglin • Aim: Disease control
Last updated Jul 16, 2026 00:00 UTC